Randomised, placebo-controlled Phase II proof of concept study of efficacy and safety of a novel rifamycin SV in situ gelling rectal solution administered by enema to patients with mild to moderate left-sided ulcerative colitis
Ulcerative colitis is a long-term condition causing swelling and ulcers in the bowel lining. In left-sided colitis, this inflammation affects the lower part of the large bowel, causing frequent diarrhoea, stomach cramps, and bleeding. This Phase II clinical trial tests a new treatment called rifamycin SV. It is given as a liquid enema that thickens into a soft gel once inside the body. This gel is designed to coat the inflamed bowel lining directly, delivering medicine where it is needed most. Participants will use either the active gel or a matching dummy enema (placebo) daily for six weeks. Doctors will check whether the treatment safely brings symptoms under control, stops rectal bleeding, and helps the bowel wall heal. The main goal is to find out if this targeted gel helps patients achieve symptom relief and clinical remission.
At a glance
What is this study about?
Ulcerative colitis is a lifelong condition where the lining of the large bowel becomes swollen, sore, and inflamed. For people with left-sided colitis, the inflammation is concentrated in the rectum and the lower section of the colon. Living with this condition can be challenging, as flare-ups often cause an urgent need to use the toilet, pain, loose stools, and rectal bleeding.
Most existing treatments involve swallowing tablets, using steroids, or taking liquid enemas. However, standard liquid enemas can sometimes leak or be hard to hold in place long enough to work well. In this study, researchers are testing an innovative liquid enema that turns into a gentle gel once inside the warmth of the body. This helps the medicine stick to the bowel wall and calm inflammation directly where it occurs.
The medicine in the gel is called rifamycin SV. It acts locally in the bowel to fight inflammation and balance gut bacteria, with very little medicine entering the rest of the bloodstream. By comparing the active gel against a harmless dummy enema (a placebo), researchers can prove whether the medicine truly helps heal the gut lining.
Developing targeted, easier-to-use treatments is vital for people with ulcerative colitis. If successful, this new gel could offer a practical, well-tolerated way to manage flare-ups and help keep the condition in remission, improving day-to-day quality of life.
Key takeaways
- Tests a novel gel enema designed to calm mild to moderate left-sided ulcerative colitis.
- The medicine turns from a liquid into a soothing gel inside the body to coat the bowel lining.
- Participants take either the active medicine or a dummy placebo once daily for six weeks.
- Healing is checked using symptom diaries, laboratory tests, and camera examinations (endoscopy).
- Joining is entirely voluntary, and you can withdraw at any time without altering your standard care.
Who may be eligible?
This trial is open to adults aged 18 and over who have been diagnosed with mild to moderate left-sided ulcerative colitis. To take part, you should currently be having active flare-up symptoms, such as increased bowel movements or noticeable rectal bleeding.
The study focuses specifically on inflammation that is limited to the left side of the bowel. It is not suitable for individuals whose inflammation reaches further up into the right side of the colon, or for those experiencing very severe flare-ups that require urgent hospital treatment.
Before you can join, the trial doctor will review your full medical history, current prescriptions, and general health to confirm whether the study is a safe and suitable option for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or over.
- I have a confirmed diagnosis of left-sided ulcerative colitis.
- My current symptoms are mild to moderate (such as bleeding or loose stools).
- I am comfortable using a daily rectal enema at home for six weeks.
- I am willing to attend clinic visits and undergo camera checks of the bowel.
What does participation involve?
Taking part in the trial involves a six-week treatment period, alongside initial health checks and follow-up visits. You will be asked to apply an 80 mL liquid enema into your back passage once a day at home. This liquid naturally thickens into a gel inside your bowel. You will be randomly chosen to receive either the active rifamycin gel or a dummy placebo gel; neither you nor your doctor will know which one you receive.
During the study, you will attend clinic visits where doctors will monitor your health using routine blood and urine tests, heart rhythm checks (ECGs), and blood pressure readings. You will also have a short camera examination of your lower bowel (endoscopy) before starting and near the end of the six weeks to see if the gut lining is healing.
Potential risks and benefits
Locations (7)
- —UnverifiedHungary
- —UnverifiedRomania
- —UnverifiedBulgaria
- —UnverifiedPoland
- —UnverifiedLithuania
- —UnverifiedLatvia
- —UnverifiedEstonia
Common questions
What does 'in situ gelling' mean?
It means the medicine goes in easily as a liquid enema, but the natural warmth inside your body turns it into a soft gel. This keeps it in place against the bowel wall.
What is a placebo and why is it used?
A placebo looks and feels identical to the study medicine but contains no active ingredient. It helps researchers prove whether health improvements are genuinely caused by the new drug.
Will using the enema be painful?
It may feel slightly unfamiliar or unusual at first, but it should not be painful. The clinical team will guide you through how to use it gently and comfortably.
What happens if my colitis flares up badly during the trial?
Your safety comes first. If your symptoms worsen, the trial doctors can immediately adjust your care, stop the trial treatment, and provide standard medications to help you.
Do I have to pay to take part in this study?
No, all study medications, clinic visits, and medical tests are provided free of charge, and travel expenses are often reimbursed.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.